Unknown

Dataset Information

0

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study.


ABSTRACT: Hospitalizations for advanced liver disease are costly and associated with significant mortality. This population-based study aimed to evaluate factors associated with in-hospital mortality and resource use for the management of hospitalized patients with cirrhosis.Mortality records and resource utilization for 52,027 patients hospitalized with cirrhosis and/or complications of portal hypertension (ascites, hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, or hepatorenal syndrome) were extracted from a nationally representative sample of Thai inpatients covered by Universal Coverage Scheme during 2009 to 2013.The rate of dying in the hospital increased steadily by 12% from 9.6% in 2009 to 10.8% in 2013 (P < .001). Complications of portal hypertension were independently associated with increased in-hospital mortality except for ascites. The highest independent risk for hospital death was seen with hepatorenal syndrome (odds ratio [OR], 5.04; 95% confidence interval [CI], 4.38-5.79). Mortality rate remained high in patients with infection, particularly septicemia (OR, 4.26; 95% CI, 4.0-4.54) and pneumonia (OR, 2.44; 95% CI, 2.18-2.73). Receiving upper endoscopy (OR, 0.29; 95% CI, 0.27-0.32) and paracentesis (OR, 0.93; 95% CI, 0.87-1.00) were associated with improved patient survival. The inflation-adjusted national annual costs (P = .06) and total hospital days (P = .07) for cirrhosis showed a trend toward increasing during the 5-year period. Renal dysfunction, infection, and sequelae of portal hypertension except for ascites were independently associated with increased resource utilization.Renal dysfunction, infection, and portal hypertension-related complications are the main factors affecting in-hospital mortality and resource utilization for hospitalized patients with cirrhosis. The early intervention for modifiable factors is an important step toward improving hospital outcomes.

SUBMITTER: Charatcharoenwitthaya P 

PROVIDER: S-EPMC5556242 | BioStudies | 2017-01-01

SECONDARY ACCESSION(S): 10.1097/MD.0000000000007782

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC7001556 | BioStudies
2020-01-01 | S-EPMC7372671 | BioStudies
2017-01-01 | S-EPMC5740797 | BioStudies
2018-01-01 | S-EPMC7090883 | BioStudies
2020-01-01 | S-EPMC7268936 | BioStudies
2019-01-01 | S-EPMC6475549 | BioStudies
2018-01-01 | S-EPMC6267395 | BioStudies
2016-01-01 | S-EPMC5028254 | BioStudies
2019-01-01 | S-EPMC6402644 | BioStudies
2012-01-01 | S-EPMC3424335 | BioStudies